2 more groups file for judicial review of mandatory drug price display
PETALING JAYA : Another health association and a group of clinics have filed for leave for judicial review of the mandatory drug price display at private healthcare facilities.
The application by the Private Medical Practitioners Association of Selangor and Kuala Lumpur (PMPASKL) and Medipulse Healthcare Sdn Bhd was filed in the Kuala Lumpur High Court yesterday.
They named the health ministry, the domestic trade and cost of living ministry, and the government as respondents.
The challenge by PMPASKL and Medipulse Healthcare against the ruling, which came into effect on May 1, comes a day after it was reported that a general practitioner and seven health groups, including the Malaysian Medical Association (MMA), had applied for leave for judicial review.
It was filed by the MMA, the Association of Private Practitioners Sabah, the Malaysian Association for the Advancement of Functional and Interdisciplinary Medicine, the Organisation of Malaysian Muslim Doctors, the Federation of Private Medical Practitioners Associations Malaysia, the Malaysian Private Dental Practitioners' Association, the Society of Private Medical Practitioners Sarawak, and one Dr Saifulbahri Ahmad.
Like PMPASKL and Medipulse Healthcare, the eight named the two ministries and the government as respondents.
They want the rule to be nullified and its enforcement stayed by the court pending the disposal of their judicial review application.
They claim that the rule, under Section 10 of the Price Control and Anti-Profiteering Act (Act 723), was gazetted in excess of the authority of the domestic trade and cost of living minister.
They contend that Section 10 of the Act cannot apply to drugs administered by health practitioners, which is provided for by Section 19 of the Poisons Act 1952 (Act 366), health news portal CodeBlue reported.
According to the document, PMPASKL and Medipulse Healthcare claim that the policy violates the Price Control and Anti-Profiteering Act 2011 as drugs prescribed by doctors are not considered 'goods' under the said legislation.
They also claim that the ruling does not take into account Section 4B of the Medicines (Advertisement and Sale) Act 1956 (Act 290) which regulates advertisements of medications.
'I believe that the order (to display medical prices) is ultra vires of the entire Health Regulatory Framework,' the affidavit, which was signed by Dr Chang Chee Seong, read. Chang is the PMPASKL's honorary secretary.
Like the judicial review filed by the eight last Thursday, Chang said he believed that no proper and adequate consultation was carried out, or comparative studies conducted, before the policy was announced.
Under the policy, private healthcare providers are required to clearly display the prices of prescription and over-the-counter medicines, traditional products, and supplements.
Medical groups opposed the policy from the start, saying it should fall under the Private Healthcare Facilities and Services Act 1998 and be delayed pending a review of general practitioners' consultation fees.
Earlier today, the health ministry said it would continue to advocate mandatory drug price displays at private healthcare facilities despite the challenge brought by medical groups to a court ruling on the matter.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Free Malaysia Today
an hour ago
- Free Malaysia Today
Health ministry to roll out free measles-rubella jabs for children
The nationwide campaign aims to boost immunisation coverage and support Malaysia's goal of eliminating measles by 2030. (File pic) PUTRAJAYA : The health ministry will roll out a free nationwide Measles‑Rubella Supplementary Immunisation Activity from Aug 4 to Oct 12 for children aged six months to 59 months. The ministry said the campaign targets children born between Aug 1, 2020, and Jan 31, 2025, aiming to strengthen the existing immunisation programme by boosting and restoring herd immunity. The programme also supports the national goal of eliminating measles by 2030, with the primary objective of raising immunisation coverage and providing early protection to prevent wider transmission, it said in a statement. Measles and rubella are highly contagious and can lead to serious complications, including ear infections, pneumonia, encephalitis, seizures, and in some cases, death. The ministry said both diseases are preventable through the MMR (measles, mumps and rubella) vaccine. Under the national immunisation programme, the MMR vaccine is administered at nine and 12 months, while Sabah administers an extra measles dose at six months. 'Overall, Malaysia's immunisation coverage has exceeded 95% annually, including in 2024. However, only 62% of districts achieved MMR coverage above 95% in 2024,' the ministry said. It said a minimum of 95% coverage is crucial to achieve herd immunity and control the spread of the disease. Official data showed measles cases nearly doubled in 2024, with 3,791 cases recorded compared to 2,002 in 2023. The number of outbreaks rose to 231, from 112 the previous year. Of the reported cases, 44.1% involved children under five years old, while 28.9% were non-citizens, of whom 84.3% had never been vaccinated. Three measles-related deaths were recorded last year, all involving unvaccinated non‑citizen children aged eight months, three years, and 17 years. The ministry urged parents and guardians to promptly bring eligible children for the free supplementary measles‑rubella (MR) vaccination. Appointments will be sent via MySejahtera, or can be made directly in the app. Walk‑ins are also accepted at government health clinics, it said.
Free Malaysia Today
7 hours ago
- Free Malaysia Today
Malaysia's first breast cancer survivor to finish an ultramarathon
On July 8, Leong Wai Leng was recognised by the Malaysia Book of Records as the 'first breast cancer survivor to complete an ultramarathon'. (Leong Wai Leng pic) PETALING JAYA : Completing any race exceeding 42.195 km is no easy feat. So when Leong Wai Leng burst out crying after running 110.5 km in 24 hours during the Melaka 24H Ultramarathon 2025, it was tears of joy. In August 2022, she was diagnosed with stage 2 breast cancer. She had taken up running a few months earlier as a way to keep fit and relieve stress. But after the diagnosis, the activity took on a deeper meaning. 'Running became my therapy. It gave me strength and a way to reclaim control over my life and body,' Leong, 50, told FMT Lifestyle. 'Running taught me endurance – not just physical, but emotional and mental. Each step reminded me that I was alive and capable. When I ran, I felt free from the label 'cancer patient', she added. Leong with her MBR certificate, along with the trophy and medal she earned from the Melaka 24H Ultramarathon 2025. (Leong Wai Leng pic) Leong vividly remembers the day she was told she had cancer. 'It was a devastating moment. I felt like my whole world collapsed. I was shocked, fearful and overwhelmed with uncertainty. 'But after the initial wave of emotions, I reminded myself that I had two children and a life to live. I had to fight, not just for myself – but for them,' said Leong, whose sons are aged 17 and 12 today. She underwent surgery to remove her left breast in December 2022 on Christmas Day. And later, a reconstruction procedure. This was followed by six cycles of chemotherapy and 15 sessions of radiotherapy until September 2023. Throughout the ordeal, she ran. In early December, just three weeks before her surgery, she completed her first full marathon – 42.195 km. 'I wanted to prove to myself that even with cancer, I could still achieve something extraordinary. 'Crossing the finish line before going into surgery felt like a powerful message, to myself and others, that cancer doesn't define or stop us,' she said. Even after the surgery, she ran. She has completed nearly 150 marathons, ultramarathons, a walkathon and trail runs across Malaysia – and even a few in the US and Thailand. Some of Leong's medals and trophies – she has participated in nearly 150 marathons, ultramarathons and trail runs to date. (Andrea Rhiannon Edmonds @ FMT Lifestyle) Her husband, Steven Im, has participated alongside her in each race. 'When I'm struggling to finish, he'd say, I'll wait for you at the finish line,' she said with a laugh, adding that his words were the motivation she needed to power through! 'My family, especially my husband and children, were my pillars of strength. Their support gave me the courage to push through the darkest times. I also held on to my faith, and the belief that I could still live a meaningful life despite the diagnosis,' she said. Determined that their children not miss out on creating memories with their mother, the couple makes it a point to include them when they travel out of town for running events. Leong is also grateful for the support of a running community she belongs to called the Malaysia Women Runners, and its founder, Safiah Galgo, as well as the organisations that sponsored her participation in several running events. Leong with her husband, Steven Im. (Andrea Rhiannon Edmonds @ FMT Lifestyle) Looking back, Leong said that the 110.5 km ultramarathon – her longest distance to date – as 'one of the toughest and most emotional experiences of her life'. Running through the night, battling fatigue, cold, and knee pain, she added, pushed her to her edge. 'But every step reminded me of my fight against cancer. I cried when I crossed the finish line. 'It wasn't just a race; it was a celebration of life, strength and survival.' On July 8, the Malaysia Book of Records named her the 'first breast cancer survivor to complete an ultramarathon', a well-deserved recognition. Leong is eyeing an even greater challenge next: a 120 km run. To others battling cancer, she shared this message: 'Never let cancer define your limits. You are stronger than you think. I started with short walks after surgery and went on to complete a 110 km ultramarathon. 'Start small, believe in your healing and surround yourself with love and support. Life after cancer is not just possible – it can be powerful, beautiful and full of victories.' Leong believes you should never let cancer define your limits. (Leong Wai Leng pic) Follow Leong Wai Leng's adventures on YouTube.
Malay Mail
a day ago
- Malay Mail
Drug price transparency kicks in at private clinics and pharmacies, full enforcement by January 2026
KUALA LUMPUR, Aug 3 — The Ministry of Health (MOH) and the Ministry of Domestic Trade and Cost of Living (KPDN) are implementing the drug price display initiative at private health facilities and community pharmacies in stages starting August 1. According to a joint statement by both ministries, the initiative, which was implemented under the Price Control and Anti-Profiteering (Price Marking of Medicines) Order 2025 [P.U.(A) 141/2025] under the Price Control and Anti-Profiteering Act 2011, began on May 1. The statement said the educational enforcement approach was implemented in the first three months ending July 31. 'During the period, 842 facilities consisting of medical clinics, dental clinics and private hospitals as well as community pharmacies were inspected and the majority of them have implemented this initiative with 57 per cent of them complying with the requirements for satisfactory drug price display,' according to the statement. In this regard, enforcement will continue in stages from August 1 through educational approach inspections and advocacy for two months until September 30 and a reminder letter may be issued in the event of non-compliance. According to the statement, starting October 1, compounds would be issued for repeat offences before full enforcement on January 1, 2026. MOH and KPDN also took note of the judicial review action filed in the High Court by seven organisations representing medical and dental practitioners and one private medical practitioner regarding the validity of Order PU (A) 141/2025. 'However, until this statement is issued, there is no court order directing the suspension of the implementation or enforcement of this order. Therefore, Order P.U.(A) 141/2025 remains valid and in force,' according to the statement. MOH and KPDN also expressed their commitment to implement the initiative in an inclusive, phased and prudent manner to ensure that its benefits are enjoyed by consumers and contribute to increasing transparency, accountability and trust in the country's health system. — Bernama
